Exact Sciences

Exact Sciences, now Abbott, is a leading provider of cancer screening and diagnostic tests. Building on the success of the Oncotype DX Breast Recurrence Score® Test and the Cologuard® stool DNA-based colorectal cancer screening test1, the company is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. More than two million breast cancer patients worldwide have now used the Oncotype DX® test to help guide treatment decisions. This test is the most commonly used genomic assay in the NHS for decision-making about adjuvant chemotherapy. 

^{1.                    This product is only available in the US}